National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their ...

Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

Now the nation’s top health official, Kennedy is reevaluating the US Health and Human Services’s contract with Moderna, which ...

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...

Moderna, Inc. (NASDAQ:MRNA) shares rose for a second day on Wednesday, adding 15.94 percent to finish at $35.21 apiece as ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

在大西洋彼岸取得的一项重大法律胜利是推动Moderna（MRNA）股票在周三大幅上涨的动力。这家以生产Spikevax新冠疫苗而闻名的公司的胜利，使股票在交易时段内上涨了近16%。相比之下，标普500指数仅上涨1.1%。

The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...

American leadership of vaccination efforts in developing countries has evaporated, along with USAid funding for the programs. New Covid-19 variants are being discovered monthly and an array of other ...

The court said Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that ...

Vaccine manufacturers would have to waive indemnity from lawsuits for injuries stemming from vaccines under a bill advancing in the Iowa Senate. Sen. Doug Campbell, R-Mason City, at a subcommittee ...